Company Filing History:
7 out of 37 
3 out of 5 
1 out of 35 
Years Active: 2000-2020
Title: Innovator Qian Peng: Pioneering Advances in Photochemical Treatments
Introduction: Qian Peng, an accomplished inventor based in Oslo, Norway, has significantly contributed to the field of phototherapy through his innovative patents. With a remarkable portfolio of 11 patents, Peng has focused on enhancing medical treatments that utilize light-activated compounds to improve patient outcomes.
Latest Patents: Among Qian Peng's latest inventions is a modification of extracorporeal photopheresis technology with porphyrin precursors. This invention utilizes photoactivatable porphyrin derivatives to treat patients by exposing their blood to specific wavelengths of light, thereby activating the therapeutic properties of these compounds. Another notable patent is related to esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy. This technology encompasses a variety of compounds that can be employed in the diagnosis and treatment of disorders affecting both external and internal surfaces of the body.
Career Highlights: Throughout his career, Qian Peng has made substantial advancements in the applications of photodynamic therapy. His work at Photocure ASA and Photocure AS has been instrumental in translating his innovative concepts into practical medical applications.
Collaborations: Qian Peng has collaborated with notable figures in the field, including Trond Warloe and Johan E Moan. Their combined expertise has fostered an environment of innovation, leading to groundbreaking developments in photochemical therapies.
Conclusion: Qian Peng's contributions to the realm of medical technology highlight the impact of innovative thinking in addressing complex health challenges. His patents not only reflect his dedication to improving treatment methodologies but also the potential of photochemical therapies to enhance patient care in the medical field.